SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters.

Salcedo-Sora, JE; Ochong, E; Beveridge, S; Johnson, D; Nzila, A; Biagini, GA; Stocks, PA; O'Neill, PM; Krishna, S; Bray, PG; et al. Salcedo-Sora, JE; Ochong, E; Beveridge, S; Johnson, D; Nzila, A; Biagini, GA; Stocks, PA; O'Neill, PM; Krishna, S; Bray, PG; Ward, SA (2011) The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters. J Biol Chem, 286 (52). pp. 44659-44668. ISSN 1083-351X https://doi.org/10.1074/jbc.M111.286054
SGUL Authors: Krishna, Sanjeev

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview

Abstract

Tetrahydrofolates are essential cofactors for DNA synthesis and methionine metabolism. Malaria parasites are capable both of synthesizing tetrahydrofolates and precursors de novo and of salvaging them from the environment. The biosynthetic route has been studied in some detail over decades, whereas the molecular mechanisms that underpin the salvage pathway lag behind. Here we identify two functional folate transporters (named PfFT1 and PfFT2) and delineate unexpected substrate preferences of the folate salvage pathway in Plasmodium falciparum. Both proteins are localized in the plasma membrane and internal membranes of the parasite intra-erythrocytic stages. Transport substrates include folic acid, folinic acid, the folate precursor p-amino benzoic acid (pABA), and the human folate catabolite pABAG(n). Intriguingly, the major circulating plasma folate, 5-methyltetrahydrofolate, was a poor substrate for transport via PfFT2 and was not transported by PfFT1. Transport of all folates studied was inhibited by probenecid and methotrexate. Growth rescue in Escherichia coli and antifolate antagonism experiments in P. falciparum indicate that functional salvage of 5-methyltetrahydrofolate is detectable but trivial. In fact pABA was the only effective salvage substrate at normal physiological levels. Because pABA is neither synthesized nor required by the human host, pABA metabolism may offer opportunities for chemotherapeutic intervention.

Item Type: Article
Additional Information: © 2011 by The American Society for Biochemistry and Molecular Biology, Inc. Author's Choice—Final version full access. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles
Keywords: Biological Transport, Active, Escherichia coli, Folic Acid, Folic Acid Antagonists, Folic Acid Transporters, Humans, Methotrexate, Plasmodium falciparum, Probenecid, Protozoan Proteins, Uricosuric Agents, Humans, Plasmodium falciparum, Escherichia coli, Probenecid, Methotrexate, Folic Acid, Protozoan Proteins, Uricosuric Agents, Folic Acid Antagonists, Biological Transport, Active, Folic Acid Transporters, Science & Technology, Life Sciences & Biomedicine, Biochemistry & Molecular Biology, BIOCHEMISTRY & MOLECULAR BIOLOGY, PARASITE PLASMODIUM-FALCIPARUM, HUMAN MALARIA PARASITE, PARA-AMINOBENZOIC ACID, UND DIE IMMUNITAT, MENSCHEN PL FALCIPARUM, ESCHERICHIA-COLI, SULFADOXINE SENSITIVITY, CONTINUOUS CULTURE, EXOGENOUS FOLATE, FOLIC-ACID, 06 Biological Sciences, 11 Medical and Health Sciences, 03 Chemical Sciences, Biochemistry & Molecular Biology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: J Biol Chem
ISSN: 1083-351X
Language: eng
Dates:
DateEvent
30 December 2011Published
13 October 2011Published Online
Publisher License: Creative Commons: Attribution-Noncommercial 3.0
Projects:
Project IDFunderFunder ID
G0400173Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDWellcome Trusthttp://dx.doi.org/10.13039/100004440
UNSPECIFIEDBill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
PubMed ID: 21998306
Web of Science ID: WOS:000298645500036
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112380
Publisher's version: https://doi.org/10.1074/jbc.M111.286054

Actions (login required)

Edit Item Edit Item